1 |
Bello BD, Spinillo A, Alberizzi P, et al (2009). Validation of the SPF10 LiPA human papillomavirus typing assay using formalin-fixed paraffin-embedded cervical biopsy samples. J Clin Microbiol, 47, 2175-80.
DOI
ScienceOn
|
2 |
Bharti AC, Shukla S, Mahata S, et al (2010). Human papillomavirus and control of cervical cancer in India. Expert Rev Obstet Gynecol, 5, 329-46.
DOI
ScienceOn
|
3 |
Bhatla N, Lal N, Bao YP, et al (2008). A meta-analysis of human papillomavirus type-distribution in women form South Asia: Implication for vaccination. Vaccine, 26, 2811-7.
DOI
ScienceOn
|
4 |
Ciapponi A, Bardach A, Glujovsky D, et al (2011). Type-specific hpv prevalence in cervical cancer and high-grade lesion in latin america and the caribbean: systematic review and meta-analysis. PLOS one,6, 1-15.
|
5 |
Characterization of human papillomavirus type 16 from infected Thai women with different cytological finding. Virus Genes, 39, 30-8.
|
6 |
Correnti M, Medina F, Cavazza ME, et al (2011). Human papillomavirus (HPV) type distribution in cervical carcinoma, low-grade, and high-grade squamous intraepithelial lesion in Venezuelan women. Gynecologic Oncol,121, 517-31.
|
7 |
Dowhanick JJ, McBride AA, Howley PM (1995). Suppression of cellular proliferation by the papillomavirus E2 protein, J Virol, 69, 7791-9.
|
8 |
Gravitt PE, van Doorn LJ, Quint W, et al (2007). Human papillomavirus (HPV) genotyping using paired exfoliated cervicovaginal cells and paraffin-embedded tissues to highlight difficulties in attributing HPV types to specific lesions. J Clin Microbiol, 45, 3245-50.
DOI
ScienceOn
|
9 |
Human Papillomavirus Typing Assay Using Formalin-Fixed Paraffin-Embedded Cervical Biopsy Samples. J Clin Microbiol, 47, 2175-80.
|
10 |
International Agency for Research on Cancer (1995). IARC Monograph on the Evaluation of Carcinogenic Risks to Human, Vol 64. Human papillomavius. IARC, Lyon.
|
11 |
Jacob MV, van den Brule AJ, Snijder PJ, et al (1996). A non-radioactive PCR enzyme-immunoassay enables a rapid identification of HPV16 and 18 in cervical scrapes after GP5+/6+ PCR. J Med Virol , 49, 223-9.
DOI
|
12 |
Lurchachaiwong W, Junyangdikul P, Payungporn S, et al (2009). Entire genome.
|
13 |
Mateos Lindemann ML, Sanchez Calvo JM, Chacon de Antonio J, et al (2011). Prevalence and distribution of high-risk genotypes of hpv in women with severe cervical lesion in madrid, spain: importance of detecting genotype 16 and other high-risk genotypes. Adv Prev Med, 10,2011.
|
14 |
Munoz N (2000). Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol, 19, 1-5.
DOI
ScienceOn
|
15 |
Ramet J, van Esso D, Meszner Z (2011). Positive paper- HPV and the primary prevention of cancer; improving vaccine uptake by paediatricians. Eur J Pediatr, 170, 309-21.
DOI
ScienceOn
|
16 |
Van Hamont D, van Ham MA, Bakkers JM, et al (2006). Evaluation of the SPF-10-INNO LiPA human papillomavirus (HPV) genotyping test and the roche linear array HPV genotyping test. J Clin Microbiol, 449, 3122-9.
|
17 |
Villiers EM, Fanquet C, Broker TR, et al (2004). Classification of papilloma-virus. Virology, 324, 17-27.
DOI
ScienceOn
|
18 |
Walboomers JM, Jacobs MV, Manos MM, et al (1999). Human papillomavirus is a necessary cause of invasive cervical cancer world-wide. J Pathol, 189, 12-9.
DOI
ScienceOn
|
19 |
World Health Organization (2010). Human paillomavirus Laboratory Manual. 1st ed. HPV Laboratory Network, WHO: Switzerland.
|
20 |
Zur Hausen H (2002). Papillomavirus and cancer: from basic studies to clinical application. Nature Rev, 2, 342-50.
DOI
ScienceOn
|